Showing results (151-160 of 258) with videos related to
Sort By:
Pageof 26
The Oncologist|November 27, 2020
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid TumorsHer-Shyong Shiah, Nai-Jung Chiang, Chia-Chi Lin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary AdenocarcinomaTony Shu Kam Mok, Sarayut Lucien Geater, Wu-Chou Su, et al.Theranostics|January 6, 2022
Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapyPei-Shan Yang, Min-Hua Yu, Ya-Chin Hou, et al.Carcinogenesis|August 1, 2012
Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cellsWen-Pin Su, Ya-Chin Lo, Jin-Jou Yan, et al.Lung Cancer (Amsterdam, Netherlands)|June 8, 2007
Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habitsChueh-Chuan Yen, Shu-Ching Liang, Yiin-Jeng Jong, et al.JTO Clinical and Research Reports|October 17, 2022
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLCYi-Long Wu, Shun Lu, James Chih-Hsin Yang, et al.Cancer|June 19, 2013
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activationEunice L Kwak, Geoffrey I Shapiro, Seth M Cohen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I TrialKenneth S Thress, Vivien Jacobs, Helen K Angell, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
A polymorphism in the APE1 gene promoter is associated with lung cancer riskYen-Li Lo, Yuh-Shan Jou, Chin-Fu Hsiao, et al.Lung Cancer (Amsterdam, Netherlands)|November 26, 2008
Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patientsYuh-Shan Jou, Yen-Li Lo, Chin-Fu Hsiao, et al.Pageof 26